KIDRON is the first Israeli-based Femtech and Women’s Health Venture Capital fund investing globally with a strategic focus on technologies addressing women’s health and wellbeing in therapeutics, medical devices, diagnostics and science based digital health in wide range of areas: autoimmune disease, heart disease, brain and cognitive health, bone health, fertility (including male), prolapse, urinary incontinence, menopause, early diagnostics of women’s cancers. 

The fund was born in the midst of the global pandemic which shifted health priorities, amplified the need for precision medicine and revealed a huge untapped market potential, capable of generating significant ROIs, while driving the impact on the quality of life of humans worldwide.   

Kidron is ideally situated in the center of the thriving Israeli healthcare innovation ecosystem, with access to cutting-edge technologies. We extend our footprint through cross ecosystem alliances, and the network of our experienced veteran team of investment, medtech and biotech industry professionals. Our rigorous assessment process and hands-on approach enable careful selection of highly innovative investment targets to bridge innovation with large scale implementation.  

We are uniquely positioned to lead the investments in this market, unlocking new opportunities for investors while transforming the way healthcare is provided to humans globally.